| 摘要 |
The present invention relates to an antagonist for nicotinic acetylcholine receptor, which contains borneol or camphor as an active ingredient. More specifically, the present invention relates to a novel medical use of a composition containing borneol represented by the following formula (1) or camphor represented by the following formula (2) as an active ingredient, which specifically inhibits nicotinic acetylcholine receptor, which plays an important role for neurological activities, to inhibit secretion of catecholamine and therefore, can be effectively used as an agent for treatment of CNS diseases such as Alzheimer's disease and Parkinson's disease, local anesthetic agent, muscle relaxant, anti-stress agent, adjuvant for prohibition of smoking and an agent for treatment of withdrawal syndrome. |
